Effects of soya oligosaccharides and soya oligopeptides on lipid metabolism in hyperlipidaemic rats

British Journal of Nutrition

Volumn 108, Issue 4, 2012, Pages 603-610

  Xie, Shali ^a,b   Zhu, Jundong ^b   Zhang, Yanqi ^b   Shi, Kai ^b   Shi, Yuangang ^b   Ma, Xiao ^a  

^a SICHUAN UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Lipid metabolism; Soya oligopeptides; Soya oligosaccharides

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; BILE ACID; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; NITRIC OXIDE; OLIGOPEPTIDE; OLIGOSACCHARIDE; PROSTACYCLIN; SOYA OLIGOPEPTIDE; SOYA OLIGOSACCHARIDE; SUPEROXIDE DISMUTASE; THROMBOXANE A2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VASOACTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; FECES LEVEL; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; SPRAGUE DAWLEY RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; APOLIPOPROTEINS; BILE ACIDS AND SALTS; DIET, HIGH-FAT; EICOSANOIDS; FECES; HYPERLIPIDEMIAS; LIPID METABOLISM; LIPID PEROXIDATION; LIPIDS; LIVER; MALE; OLIGOPEPTIDES; OLIGOSACCHARIDES; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SEEDS; SOYBEAN PROTEINS; SOYBEANS; SUPEROXIDE DISMUTASE;

EID: 84865275515     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511006015     Document Type: Article

References (50)

1. World Health Organization (2008) The Global Burden of Disease: 2004 Update. Geneva, Switzerland: WHO. http://www.who.int/healthinfo/global-burden- disease/GBD-report-2004update-full.pdf (accessed September 2010).
2. Lusis AJ (2000) Atherosclerosis. Nature 407, 233-241.
3. Halpern MJ (1995) Lipids and atherosclerosis. Mol Aspects Med 16, 509-710. (Pubitemid 26072097)
4. Rader DJ & Puré E (2005) Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell? Cell Metab 1, 223-230. (Pubitemid 43960611)
5. Steinberg D, Parthasarathy S, Carew TE, et al. (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320, 915-924. (Pubitemid 19101597)
6. Brown BG, Stukovsky KH & Zhao XQ(2006) Simultaneous lowdensity lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trials. Curr Opin Lipidol 17, 631-636. (Pubitemid 44729955)
7. Armitage J (2007) The safety of statins in clinical practice. Lancet 370, 1781-1790. (Pubitemid 350137473)
8. Bruckert E & Rosenbaum D (2011) Lowering LDL-cholesterol through diet: potential role in the statin era. Curr Opin Lipidol 22, 43-48.
9. Sugano M, Goto S, Yamada Y, et al. (1990) Cholesterollowering activity of various undigested fractions of soybean protein in rats. J Nutr 120, 977-985. (Pubitemid 20306058)
10. Anderson JW, Johnstone BM & Cook-Newell ME (1995) A meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333, 276-282.
11. Taylor GR & Williams CM (1998) Effects of probiotics and prebiotics on blood lipids. Br J Nutr 80, S225-S230. (Pubitemid 28510692)
12. Lan Y, Williams BA, Verstegena MWA, et al. (2007) Soy oligosaccharides in vitro fermentation characteristics and its effect on caecal microorganisms of young broiler chickens. Anim Feed Sci Technol 133, 286-297. (Pubitemid 46108413)
13. Bezkorovainy A (2001) Probiotics: determinants of survival and growth in the gut. Am J Clin Nutr 73, 399S-405S. (Pubitemid 32113262)
14. Ikeda T, Shibuya Y, Senba U, et al. (1991) Automated immunoturbidimetric analysis of six plasma apoliproteins: correlation with radial immunodiffusion assays. J Clin Lab Anal 5, 90-95.
15. Oyanagui Y (1984) Reevaluation of assay methods and establishment of kit for superoxide dismutase activity. Anal Biochem 142, 290-296. (Pubitemid 15177262)
16. Chen CY, Huang YL & Lin TH (1998) Association between oxidative stress and cytokine production in nickel-treated rats. Arch Biochem Biophys 356, 127-132.
17. Bouaziz A, Marie M, Richert A, et al. (1998) Direct physical factors and PGI2 and TXA2 secretions by a human endothelial cell line: in vitro investigation of pressure and shear stress applied independently or in synergy. Thromb Res 90, 279-289. (Pubitemid 28383789)
18. Hong NK & Meng CW (1983) Determination of total bile acids in bile by phosphomolybdate colorimetry. Shanghai Med J 6, 35-37.
19. Tonstad S, Smerud K & Høie L (2002) A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr 76, 78-84. (Pubitemid 34686552)
20. Teixeira SR, Potter SM, Weigel R, et al. (2000) Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr 71, 1077-1084. (Pubitemid 30230553)
21. Hori G, Wang MF, Chan YC, et al. (2001) Soy protein hydrolyzate with bound phospholipids reduces serum cholesterol levels in hypercholesterolemic adult male volunteers. Biosci Biotechnol Biochem 65, 72-78. (Pubitemid 33617443)
22. Duranti M, Lovati MR, Dani V, et al. (2004) The alpha' subunit from soybean 7S globulin lowers plasma lipids and upregulates liver beta-VLDL receptors in rats fed a hypercholesterolemic diet. J Nutr 134, 1334-1339. (Pubitemid 38720703)
23. Zhong F, Zhang XM, Ma JG, et al. (2007) Fractionation and identification of a novel hypocholesterolemic peptide derived from soy protein Alcalase hydrolysates. Food Res Int 40, 756-762. (Pubitemid 46669994)
24. Chen H, Liu LJ, Zhu JJ, et al. (2010) Effect of soybean oligosaccharides on blood lipid, glucose levels and antioxidant enzymes activity in high fat rats. Food Chem 119, 1633-1636.
25. Bang MH, Chio OS & Kim WK (2007) Soy oligosaccharide increases fecal bifidobacteria counts, short-chain fatty acids, and fecal lipid concentrations in young Korean women. J Med Food 10, 366-370.
26. Bornet F, Alamowitch C & Slama G (1994) Short chain fatty acids and metabolic effects in humans. In Gum and Stabilisers for Food Industry, 7th ed., pp. 217-229 [GO Philips, DJ Weldlock and TE Williams, editors]. Oxford: Oxford University Press.
27. Trautwein EA, Rieckhoff D & Erbersdobler HF (1998) Dietary inulin lowers plasma cholesterol and triacylglycerol and alters biliary bile acid profile in hamsters. J Nutr 128, 1937-1943. (Pubitemid 28509858)
28. Sirtori CR & Fumagalli R (2006) LDL-cholesterol lowering or HDL-cholesterol raising for cardiovascular prevention. A lesson from cholesterol turnover studies and others. Atherosclerosis 186, 1-11.
29. Hermansen K, Sondergaard M, Høie L, et al. (2001) Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 24, 228-233. (Pubitemid 32119116)
30. Zhao XJ, Wang XX, Wu BX, et al. (2002) Regulation effects of soy active peptides on lipid parameters of rats fed a high fat diet. Chin J Health Lab Technol 12, 421-422.
31. Erdmann K, Cheung BW & Schröder H (2008) The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease. J Nutr Biochem 19, 643-654.
32. Lovati MR, Manzoni C, Gianazza E, et al. (2000) Soy protein peptides regulate cholesterol homeostasis in Hep G2 cells. J Nutr 130, 2543-2549.
33. Manzoni C, Duranti M, Eberini I, et al. (2003) Subcellular localization of soybean 7S globulin in HepG2 cells and LDL receptor up-regulation by its alphaV constituent subunit. J Nutr 133, 2149-2155. (Pubitemid 36841531)
34. Walldius G, Jungner I, Aastveit AH, et al. (2004) The apoB/ apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med 42, 1355-1363. (Pubitemid 40057822)
35. Sitia S, Tomasoni L, Atzeni F, et al. (2010) From endothelial dysfunction to atherosclerosis. Autoimmun Rev 9, 830-834.
36. Praticò D, Cyrus T, Li H, et al. (2000) Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis. Blood 96, 3823-3826.
37. Naseem KM (2005) The role of nitric oxide in cardiovascular diseases. Mol Aspects Med 26, 33-65. (Pubitemid 40250164)
38. Var A, Yildirim Y, Onur E, et al. (2003) Endothelial dysfunction in preeclampsia. Increased homocysteine and decreased nitric oxide levels. Gynecol Obstet Invest 56, 221-224. (Pubitemid 37505854)
39. Dusting GJ, Hyland R, Hickey H, et al. (1995) Angiotensinconverting enzyme inhibitors reduce neointimal thickening and maintain endothelial nitric oxide function in rabbit carotid arteries. Am J Cardiol 76, 24E-27E.
40. Ringseis R, Matthes B, Lehmann V, et al. (2005) Peptides and hydrolysates from casein and soy protein modulate the release of vasoactive substances from human aortic endothelial cells. Biochim Biophys Acta 1721, 89-97. (Pubitemid 40093516)
41. Mesa MD, Silván JM, Olza J, et al. (2008) Antioxidant properties of soy protein-fructooligosaccharide glycation systems and its hydrolyzates. Food Res Int 41, 606-615.
42. Mahfouz MM & Kummerow FA (2000) Cholesterol-rich diets have different effects on lipid peroxidation, cholesterol oxides, and antioxidant enzymes in rats and rabbits. J Nutr Biochem 11, 293-302. (Pubitemid 30392416)
43. Watanabe S & Fukui T (2000) Suppressive effect of curcumin on trichloroethylene-induced oxidative stress. J Nutr Sci Vitaminol (Tokyo) 46, 230-234. (Pubitemid 32010159)
44. Arafa HM (2005) Curcumin attenuates diet-induced hypercholesterolemia in rats. Med Sci Monit 11, BR228-BR234. (Pubitemid 40992191)
45. Gibbs BF, Zougman A, Masse R, et al. (2004) Production and characterization of bioactive peptides from soy hydrolysate and soy-fermented food. Food Res Int 37, 123-131. (Pubitemid 38214957)
46. Takenaka A, Annaka H, Kimura Y, et al. (2003) Reduction of paraquat-induced oxidative stress in rats by dietary soy peptide. Biosci Biotechnol Biochem 67, 278-283. (Pubitemid 39251978)
47. Chen HM, Muramoto K, Yamauchi F, et al. (1996) Antioxidant activity of designed peptides based on the antioxidative peptide isolated from digests of a soybean protein. J Agric Food Chem 44, 2619-2623. (Pubitemid 126453550)
48. Anderson JW & Siesel AE (1990) Hypocholesterolemic effects of oat products. In New Developments In Dietary Fiber: Physiological, Physiochemical, and Analytical Aspects, pp. 17-36 [I Furda and CJ Brine, editors]. New York, NY: Plenum Press.
49. Iwami K, Sakakibara K & Ibuki F (1986) Involvement of postdigestion hydrophobic peptides in plasma cholesterol-lowering effect of dietary plant protein. Agric Biol Chem 50, 1217-1222.
50. Choi SK, Adachi M & Utsumi S (2002) Identification of the bile acid-binding region in the soy glycinin A1aB1b subunit. Biosci Biotechnol Biochem 66, 2395-2401. (Pubitemid 39251176)